Terns Pharmaceuticals (TERN) Accumulated Depreciation & Amortization (2020 - 2022)
Historic Accumulated Depreciation & Amortization for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $1.4 million.
- Terns Pharmaceuticals' Accumulated Depreciation & Amortization rose 1831.22% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.4 million, marking a year-over-year increase of 1831.22%. This contributed to the annual value of $1.4 million for FY2022, which is 1831.22% up from last year.
- Per Terns Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $1.4 million for Q4 2022, which was up 1831.22% from $1.2 million recorded in Q4 2021.
- Terns Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $1.4 million during Q4 2022, with a 5-year trough of $689000.0 in Q4 2020.
- Over the past 3 years, Terns Pharmaceuticals' median Accumulated Depreciation & Amortization value was $1.2 million (recorded in 2021), while the average stood at $1.1 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 7198.84% in 2021, then soared by 1831.22% in 2022.
- Terns Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $689000.0 in 2020, then skyrocketed by 71.99% to $1.2 million in 2021, then rose by 18.31% to $1.4 million in 2022.
- Its last three reported values are $1.4 million in Q4 2022, $1.2 million for Q4 2021, and $689000.0 during Q4 2020.